For pharma

Decades of research, sitting in storage.

Your trials, assays and lab notebooks hold signal that scientific AI can't get anywhere else. Mullion prepares it, protects it and licenses it, with your approval at every step.

What qualifies

Including the work that didn't make it.

Failed programmes and negative results are some of the most valuable data for AI, because they are almost never published.

Clinical trials

Protocols, outcomes and analyses, including terminated studies.

Assays & screens

Screening libraries and assay results, positives and negatives.

Lab notebooks

Medicinal chemistry records with the reasoning behind each step.

Regulatory & safety

Study reports, submissions and pharmacovigilance records.

Readiness check

Is your data ready for AI?

Four questions, under a minute. Nothing you enter leaves this page.

Privacy & compliance

Protected before it moves.

De-identified in your environment

Patient data is de-identified inside your systems, to HIPAA and GDPR standards, before anything leaves.

You approve every buyer

Exclude competitors, restrict uses and set terms for each licence.

No IP exposure

Active programmes and sensitive compounds can be held back or delayed.

Full audit trail

Every dataset is logged: what was shared, with whom, and under which terms.

How it works

From archive to licence.

01

Discovery

We map what you hold with your data, legal and privacy teams, and agree what is in scope.

02

Prepare

Extract, normalise and de-identify, working inside your environment wherever possible.

03

License

Approved datasets are licensed to vetted AI developers. You earn on every licence.

Put finished research back to work.